Navigation Links
Bad Enzymes Found To Enable Brain Recovery Following Stroke

The same enzymes that cause brain damage following an acute attack of stroke could be beneficial some time later. This finding perhaps highlights that effective treatment // of stroke could be possible if administered few weeks following the stroke, instead of the treatment within couple of hours following stroke. Additionally, it could open avenues for the development of novel stroke treatment strategies and new generation drugs in treating the same.

The enzyme matrix metalloproteinase-9 (MMP-9) has been found to help in remodeling of the brain 14 days following stroke, in experiments conducted on animal mouse models by Harvard medical school researchers. The results of the study can be found in April issue of the Nature Medicine journal.

The enzymes serve to breakdown the complex structure that surrounds the cells, known as the extracellular matrix. The compound has been found to result in growth of new blood vessel in the damaged brain region. In addition it induces cell growth, cell differentiation and movement of the cells.

Stroke occurs due to a temporary loss of blood supply to the brain. This can occur either due to blockage of a blood vessel though blood clot or rupture of a blood vessel, supplying the brain. Following stroke, MMPs eat away the damaged brain tissue, increasing risk of inflammation and brain hemorrhage.

Current treat of stroke is directed at inhibiting the effect of these damage-causing MMPs. The only FDA-approved medication for the treatment of stroke is tissue plasminogen activator (tPA). This has to be administered with three hours of an acute stroke episode, to prevent irreversible damage to the brain.

Rats that were designed to mimic human models of stroke were given different doses of the MMP inhibitor, at different intervals. Administration of the inhibitor immediately following the stroke showed smaller brain damaged areas. No effect was observed when it was administered thr ee days following stroke. Extensive brain damage was seen when the inhibitor was given at 7 or 14 days after stroke.

Surprisingly, high levels of the MMPs were found adjacent to the damaged area, more specifically in the peri-infarct cortex, an area that enables recovery of the brain following stoke.

'We have mostly thought of MMPs as being bad. Our data strongly suggest that they play a totally different role during stroke recovery. The peri-infarct zone is very dynamic and potentially very malleable for long periods of time after stroke,' said Eng H. Lo, from the Neuroprotection Research Laboratory at Massachusetts General Hospital.

The researchers have however warned about the use of these compounds in stroke management, as the activity of the MMPs has to be regulated to ensure an optimal recovery of the stroke patient.


'"/>




Related medicine news :

1. Smoking Hazardous To The Enzymes System In Lungs
2. New Role of COX Enzymes Discovered
3. Immune System Gears Up by Specific Enzymes
4. Study Attributes Elevated Liver Enzymes in HIV/hepatitis to Coinfection Rather Than Antiretrovirals
5. Fluoride Found Effective in Osteoporosis
6. Implantable Contact Lens Found Safe and Effective
7. Cancer hazard Found With Animal-Based Nutrients
8. Processed Meat, Diabetes connection Found
9. Night Time Aspirin Regimen Found to Reduce Blood Pressure
10. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
11. Hydrotherapy Found to be Effective for Patients with Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... ... years, Doctors on Liens has published a directory of the top doctors working ... When the company started in 1997, the directory was a single page focusing on chiropractors ... directory features a vast array of medical specialists stretching from Sacramento to San ...
(Date:12/2/2016)... ... December 02, 2016 , ... Center for Autism and ... of those affected by autism spectrum disorder (ASD) and other developmental disabilities. The group, ... will give parents and other caregivers the opportunity to share stories and advice, seek ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, ... standing as living proof that attitude and determination can combine into the most ... spike around the holidays. This campaign will offer patients a new-found hope, by ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite helps biobanks, clinical, research ... labeling, storing, shipping and disposal. The new version is a faster and a ...
(Date:12/2/2016)... Wexford, PA (PRWEB) , ... December 02, 2016 , ... ... manages stress and overall health, day and night. No other wearable health technology on ... management. We wanted to give poeple more meaningful insights about their health than ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016  LifeVac, the revolutionary ... included in the Emergency Response Training and Support Services ... excited to have LifeVac become part of the ERTSS ... Founder and CEO of LifeVac. "Having an established network ... and effectively will help leverage our efforts to spread ...
(Date:12/2/2016)... -- PipelineRx, a leading medication management technology company focused ... its SaaS-based telepharmacy platform, PowerGridRx™ , at ... Clinical Meeting and Exhibition, December 5-7 in ... hospital clients nationally, the Company is a leader ... improve pharmacy operations, enhance patient safety, and reduce ...
(Date:12/2/2016)... 2, 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today ... Inc. ("PSI").  The combination of Texas -based ... -based PSI bring together both company,s clinical expertise and high-touch ... an industry-leading specialty pharmacy. About Maxor ... , , ...
Breaking Medicine Technology: